CJC-1295 + Ipamorelin
Peptides

CJC-1295 + Ipamorelin

CJC-1295 with Ipamorelin Stack

A synergistic peptide combination that stimulates natural growth hormone release. Widely used for anti-aging, body composition improvement, and recovery enhancement.

BGRADE · Moderate
35+ Studies90+ ReportsModerateInjectableAvailable in UAE
74
Kamura ScoreStrong
74/100
Strong
Moderate
Evidence
2-4 weeks
Time to Effect
AED 800-2,000/month
Est. Cost
Available
UAE Access
Last reviewed: March 2026
75
Research
78
Safety
70
Access
65
Value

How CJC-1295 + Ipamorelin Works

CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue with a Drug Affinity Complex (DAC) that extends its half-life to 6-8 days, while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. When combined, CJC-1295 amplifies the natural GHRH signal and Ipamorelin triggers GH release from the pituitary, producing a synergistic increase in growth hormone output that mimics youthful pulsatile GH secretion without significantly raising cortisol or prolactin.

📊 Evidence by Outcome

Growth Hormone ReleaseA

Well-established GH secretagogue effect. Increases natural GH pulse without shutting down endogenous production.

15 studies • Consistency: High • Effect: Large

Body CompositionB

Improved fat loss and lean mass gains when combined with exercise. Effects are moderate but consistent.

8 studies • Consistency: Moderate • Effect: Moderate

Sleep QualityB

Many users report deeper sleep and more vivid dreams. GH release primarily occurs during sleep.

5 studies • Consistency: Moderate • Effect: Moderate

📄

Key Research

Peer-Reviewed Evidence • 3 Citations

[1]

Prolonged stimulation of growth hormone secretion after a single administration of CJC-1295

Teichman SL et al.J Clin Endocrinol Metab2006PMID: 16352683

Key Finding: Single dose of CJC-1295 produces sustained GH elevation for 6+ days with dose-dependent increases in IGF-1.

View on PubMed
[2]

Ipamorelin, the first selective growth hormone secretagogue

Raun K et al.Eur J Endocrinol1998PMID: 9725779

Key Finding: Ipamorelin selectively releases GH without affecting cortisol or prolactin levels, providing a cleaner hormonal profile than other GH secretagogues.

View on PubMed
[3]

Growth hormone secretagogues: History, mechanism of action, and clinical development

Nass R et al.Pituitary2011PMID: 21476061

Key Finding: GH secretagogues like ipamorelin show promise for treating age-related GH decline with favorable safety profiles in clinical trials.

View on PubMed

Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.

Side Effects & Safety

Common(4)
Increased hunger (especially in first 1-2 weeks)Water retention and mild bloatingTingling or numbness in hands/feetVivid dreams and improved sleep depth
Rare(4)
HeadacheMild joint stiffnessTemporary lightheadedness post-injectionFlushing
Serious(3)
Potential for elevated blood glucose with prolonged useTheoretical pituitary overstimulation with excessive dosingCarpal tunnel-like symptoms at high doses (reversible)

Interactions & Contraindications

Drug Interactions

  • May interfere with diabetes medications (affects insulin sensitivity and blood glucose)
  • May interact with corticosteroids (both affect growth hormone axis)
  • Caution with other growth hormone secretagogues (additive effect on GH release)

Supplement Interactions

  • Synergistic with arginine and ornithine for GH release
  • GABA supplementation may amplify GH response
  • Melatonin co-administration may enhance sleep-related GH pulse

Food & Timing

  • Must be taken on an empty stomach (food, especially carbs and fats, blunts GH release)
  • Avoid eating for 30-60 minutes after injection
  • Evening dosing before bed is common to align with natural GH pulse

Who Should Avoid

  • Active cancer or history of cancer (growth hormone promotes cell proliferation)
  • Active pituitary disorders or tumors
  • Diabetes (may alter glucose metabolism)
  • Pregnancy and breastfeeding
  • Children under 18 (may interfere with normal growth patterns)
  • Intracranial hypertension

📋 Protocol Snapshot

Standard Protocol
CJC 100mcg + Ipa 100mcg
SubQ injection before bed. 5 days on, 2 days off.
Aggressive Protocol
CJC 200mcg + Ipa 200mcg
Twice daily (morning + before bed). 12-week cycles.
Maintenance
CJC 100mcg + Ipa 100mcg
3x per week. For long-term anti-aging maintenance.

Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.

Cost Guide

AED 800-2,000/month

Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.

Frequently Asked Questions

These peptides are available through licensed wellness clinics and compounding pharmacies in the UAE. They are not scheduled controlled substances but are not approved as pharmaceutical drugs. A prescription or clinical consultation is typically required.

Improved sleep quality is often noticed within 1-2 weeks. Fat loss and body composition changes typically become apparent at 6-12 weeks. Full anti-aging benefits may take 3-6 months of consistent use.

Most protocols recommend injection before bed on an empty stomach (at least 2 hours after last meal) to align with the body's natural nocturnal growth hormone pulse. Some protocols include a morning dose as well.

No. CJC-1295/Ipamorelin stimulates your pituitary to produce and release its own growth hormone in a natural pulsatile pattern. Exogenous HGH bypasses the pituitary entirely and provides a constant, non-physiological level. The peptide approach is considered safer and maintains feedback regulation.

Yes, it is commonly stacked with BPC-157 (for tissue repair), TB-500 (for recovery), or MOTS-c (for metabolic benefits). Avoid combining with other GH secretagogues without clinical guidance to prevent excessive GH elevation.

Where to Get It (UAE)

Browse all wellness centers →

Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, safety, accessibility, and value — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.

My Stack

0 treatments

🧪

Your stack is empty. Browse treatments and click + to build your protocol.